108937 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on ester bonds (3.1) Ribonucleases RNAses, DNAses
CRISPR CPF1 direct repeat variants
#4802Strong insulator and uses thereof in gene delivery
#4803CasY compositions and methods of use
#4804CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING BETA HEMOGLOBINOPATHIES
#4805Abiotic stress tolerant plants and polynucleotides to improve abiotic stress and methods
#4806Selenium Cancer Therapy
#4807NUCLEIC ACID APTAMER FOR INHIBITING ACTIVITY OF GENOME-EDITING ENZYME
#4808NOVEL CRISPR-ASSOCIATED TRANSPOSON SYSTEMS AND COMPONENTS
#4809NOVEL CRISPR-ASSOCIATED TRANSPOSON SYSTEMS AND COMPONENTS
#4810METHODS AND COMPOSITIONS FOR ALTERING FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND/OR DOMAINS
#4811PROSS OPTIMIZED ENZYMES
#4812Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#4813Methods of treating an ischemic disease
#4814NANOS knock-out that ablates germline cells
#4815RNA targeting methods and compositions
#4816NUCLEIC ACID-BASED DATA STORAGE
#4817Modifying the specificity of plant non-coding RNA molecules for silencing gene expression
#4818Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis
#4819GENOMIC SEQUENCE MODIFICATION METHOD FOR SPECIFICALLY CONVERTING NUCLEIC ACID BASES OF TARGETED DNA SEQUENCE, AND MOLECULAR COMPLEX FOR USE IN SAME
#4820Enhanced selection of efficient targeted genome manipulating agents
#4821CRISPR/CAS-CYTIDINE DEAMINASE BASED COMPOSITIONS, SYSTEMS, AND METHODS FOR TARGETED NUCLEIC ACID EDITING
#4822COMPOSITIONS AND METHODS FOR TREATMENT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)-RELATED DISORDERS
#4823Targetable 3`-Overhang Nuclease Fusion Proteins
#4824RNA-guided endonuclease fusion polypeptides and methods of use thereof
#4825Detergent composition
#4826COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES
#4827Cancer treatment methods using thermotherapy and/or enhanced immunotherapy
#4828RNA targeting methods and compositions
#4829METHODS AND COMPOSITIONS FOR USE OF TREX2 AS DIAGNOSTIC AND PROGNOSTIC MARKER FOR CANCER
#4830Bioinformatics methods of in silico validation and selection of circRNAs
#4831Compositions and methods for regulating proteins and nucleic acids activities
#4832METHOD, LYSIS SOLUTION AND KIT FOR SELECTIVELY DEPLETING ANIMAL NUCLEIC ACIDS IN A SAMPLE
#4833Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
#4834Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/CAS9
#4835Dynamic control of colocalization of proteins
#4836Extracellular matrix-producing composition using MAST4 gene and preparation method therefor
#4837Methods and compositions for the treatment of lysosomal storage diseases
#4838Artifical nucleases comprising engineered cleavage half-domains
#4839NUCLEIC ACID-GUIDED NUCLEASES
#4840TARGETED CHROMOSOMAL MUTAGENESIS USING ZINC FINGER NUCLEASES
#4841NOVEL TYPE VI CRISPR ORTHOLOGS AND SYSTEMS
#4842Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
#4843Compositions and methods for transient delivery of nucleases
#4844Materials and methods for increasing gene editing frequency
#4845T-cells expressing anti-LIV1 chimeric antigen receptor
#4846TCRS SPECIFIC FOR MINOR HISTOCOMPATIBILITY (H) ANTIGEN HA-1 AND USES THEREOF
#4847ISOLATION OF EXTRACELLULAR VESICLES (EVS) FROM RED BLOOD CELLS FOR GENE THERAPY
#4848Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing
#4849GENOME EDITING METHOD
#4850Targeted gene insertion for improved immune cells therapy
#4851PROCESS FOR DNA INTEGRATION USING RNA-GUIDED ENDONUCLEASES
#4852Automated instrumentation for production of T-cell receptor peptide libraries
#4853DELIVERY OF A GENE-EDITING SYSTEM WITH A SINGLE RETROVIRAL PARTICLE AND METHODS OF GENERATION AND USE
#4854MATERIALS AND METHODS FOR TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2 (SCA2) AND OTHER SPINOCEREBELLAR ATAXIA TYPE 2 PROTEIN (ATXN2) GENE RELATED CONDITIONS OR DISORDERS
#4855Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency
#4856Transposase polypeptides and uses thereof
#4857CAS12a MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME
#4858GENE EDITING T CELL AND USE THEREOF
#4859Methods and compositions for overcoming immunosuppression
#4860Nucleic acid, chimeric antigen receptor expression plasmid, chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer
#4861COMPOSITIONS AND METHODS FOR PRODUCING EXOSOME LOADED THERAPEUTICS FOR THE TREATMENT OF MULTIPLE ONCOLOGICAL DISORDERS
#4862Sequential gene editing in primary immune cells
#4863Scarless genome editing through two-step homology directed repair
#4864Universal self-regulating mammalian cell line platform for the production of biologics
#4865Oleic Acid-Enriched Plant Body Having Genetically Modified FAD2 And Production Method Thereof
#4866Engineered nucleic acid-targeting nucleic acids
#4867Materials and methods for efficient targeted knock in or gene replacement
#4868Methods and compositions using one-sided transposition
#4869Genomic sequence modification method for specifically converting nucleic acid bases of targeted DNA sequence, and molecular complex for use in same
#4870Using nucleosome interacting protein domains to enhance targeted genome modification
#4871Engineered CAS9 variants
#4872TAXONOMY AND USE OF BONE MARROW STROMAL CELL
#4873GENOME-EDITED NK CELL AND METHODS OF MAKING AND USING
#4874CHIMERIC RECEPTORS
#4875Methods of treating mitochondrial disorders
#4876Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
#4877Biosynthesis of curcuminoids in mammalian cells
#4878Artificial genome manipulation for gene expression regulation
#4879Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene
#4880Compositions and methods for genome editing
#4881A GUIDE-RNA EXPRESSION SYSTEM FOR A HOST CELL
#4882Compositions and methods for non-antibiotic treating of bacterial infections by blocking or disrupting bacterial genes involved in virulence or viability
#4883RNA targeting methods and compositions
#4884Cas proteins with reduced immunogenicity and methods of screening thereof
#4885NOVEL DNASE
#4886Site-specific enzymes and methods of use
#4887Variant Cas9 polypeptides comprising internal insertions
#4888Compositions and methods for treating alzheimer's disease
#4889POROUS NANOPARTICLE-SUPPORTED LIPID BILAYER DELIVERY OF TRANSCRIPTIONAL GENE MODULATORS
#4890Methods And Compositions For Controlling Cardiac Fibrosis And Remodeling
#4891Nuclease-mediated repeat expansion
#4892Assessing nuclease cleavage
#4893Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4894METHODS FOR REDUCING DNA-INDUCED CYTOTOXICITY AND ENHANCING GENE EDITING IN PRIMARY CELLS
#4895In vitro recombination method
#4896Recombinant lentiviral vector for stem cell- based gene therapy of sickle cell disorder
#4897Method of Off-Target Recording of Spacer Sequences within a Cell In Vivo
#4898Methods of targeted genetic alteration in plant cells
#4899METHODS FOR IDENTIFYING ACTIVATORS AND SUPPRESSORS
#4900CREATION AND USE OF GUIDE NUCLEIC ACIDS
#4901CRISPR-CAS systems for genome editing
#4902High efficiency base editors comprising Gam
#4903Anti-CRISPR polynucleotides and polypeptides and methods of use
#4904CRISPR-associated transposase systems and methods of use thereof
#4905Chimeric receptor binding proteins for use in bacterial delivery vehicles
#4906Methods and compositions for cluster generation by bridge amplification
#4907In vitro isolation and enrichment of nucleic acids using site-specific nucleases
#4908Repairing compound heterozygous recessive mutations by allele exchange
#4909Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
#4910NANOPARTICLE-MEDIATED GENE DELIVERY, GENOMIC EDITING AND LIGAND-TARGETED MODIFICATION IN VARIOUS CELL POPULATIONS
#4911Compositions of self-reporting transposon (SRT) constructs and methods for mapping transposon insertions
#4912Systems, methods, and compositions for targeted nucleic acid editing
#4913Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
#4914Gene-regulating compositions and methods for improved immunotherapy
#4915Needle-based devices and methods for in vivo diagnostics of disease conditions
#4916METHOD FOR KNOCKING OUT TARGET GENE IN T CELL IN VITRO AND crRNA USED IN THE METHOD
#4917Engineered enzymes
#4918COMPOSITIONS AND METHODS FOR SITE-DIRECTED DNA NICKING AND CLEAVING
#4919ENGINEERING OF MONOMERIC, RED-SHIFTED, AND BRIGHTER VARIANTS OF iRFP USING STRUCTURE-GUIDED MULTI-SITE MUTAGENESIS
#4920Compositions and methods for treatment of peroxisome proliferator-activated receptor gamma (PPARG) activated cancer
#4921Treatment of retinitis pigmentosa using engineered meganucleases
#4922MYB-RELATED TRANSCRIPTION FACTOR (MYPOP) AS DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR TUMOR THERAPY
#4923Method for Fragmenting Genomic DNA Using CAS9
#4924Modified Cpf1 MRNA, modified guide RNA, and uses thereof
#4925CRISPR-CAS system for a yeast host cell
#4926Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
#4927REPROGRAMMING METABOLISM BY INHIBITING VHL FOR TREATMENT OF NEURODEGENERATION
#4928Epigenetically Regulated Site-Specific Nucleases
#4929USING SPLIT DEAMINASES TO LIMIT UNWANTED OFF-TARGET BASE EDITOR DEAMINATION
#4930CasZ compositions and methods of use
#4931Base editors with improved precision and specificity
#4932Compositions for increasing polypeptide stability and activity, and related methods
#4933Stabilized nucleic acids encoding messenger ribonucleic acid (mRNA)
#4934GENE THERAPY FOR TREATMENT OF INFERTILITY
#4935METHODS OF INHIBITING FUNGAL CERAMIDE SYNTHASE FOR TREATMENT OF CRYPTOCOCCUS NEOFORMANS INFECTION
#4936Multiplexed genome editing
#4937CRISPR-CAS system for a lipolytic yeast host cell
#4938Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
#4939Mammalian cells for producing a secreted protein
#4940CRISPR SYSTEM BASED ANTIVIRAL THERAPY
#4941Multiplex Guide RNAS
#4942APHERESIS METHODS AND USES
#4943RIBONUCLEOPROTEIN-BASED IMAGING AND DETECTION
#4944NEGATIVE-POSITIVE ENRICHMENT FOR NUCLEIC ACID DETECTION
#4945Compositions and methods related to a type-II CRISPR-Cas system in
#4946CRISPR enabled multiplexed genome engineering
#4947CRISPR enabled multiplexed genome engineering
#4948ENHANCED MODIFIED VIRAL CAPSID PROTEINS
#4949Compositions and methods for gene editing
#4950METHODS OF PRODUCING HUMAN CANCER CELL MODELS AND METHODS OF USE
#4951METHODS TO IMPROVE PLANT AGRONOMIC TRAIT USING BCS1L GENE AND GUIDE RNA/CAS ENDONUCLEASE SYSTEMS
#4952Programmable transcription factors and methods
#4953METHODS AND SYSTEMS FOR CONDITIONALLY REGULATING GENE EXPRESSION
#4954Automated cell processing methods, modules, instruments, and systems
#4955METHOD TO ENHANCE SCREENING FOR HOMOLOGOUS RECOMBINATION IN GENOME EDITED CELLS USING RECOMBINATION-ACTIVATED FLUORESCENT DONOR DELIVERY VECTOR
#4956PEPTIDE-MEDIATED DELIVERY OF RNA-GUIDED ENDONUCLEASE INTO CELLS
#4957Systems and methods for the treatment of hemoglobinopathies
#4958Methods and products for transfecting cells
#4959Therapeutic Membrane Vesicles
#4960CRISPR/RNA-guided nuclease systems and methods
#4961Genetic engineering of macrophages for immunotherapy
#4962Yeast strain with glucose and xylose co-utilization capacity
#4963METHODS AND COMPOSITIONS FOR GENOME EDITING
#4964Self-inactivating endonuclease-encoding nucleic acids and methods of using the same
#4965Gene Therapy Drug for Granular Corneal Degeneration
#4966REGULATION OF TRANSCRIPTION THROUGH CTCF LOOP ANCHORS
#4967METHODS AND COMPOSITIONS RELATING TO HOMOLOGY-DIRECTED REPAIR
#4968Engineered CRISPR-Cas9 nucleases
#4969Engineered CRISPR-Cas9 nucleases with altered PAM specificity
#4970Target-specific CRISPR mutant
#4971System and method for genome editing
#4972High-fidelity CAS9 variants and applications thereof
#4973Special fire protection system for runaway grass and forest fires and method for use
#4974NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF
#4975Nano-liposome carrier composition containing hybrid of Cas9 protein and guide RNA
#4976METHODS AND COMPOSITIONS FOR MODULATING INNATE LYMPHOID CELL PATHOGENIC EFFECTORS
#4977CRISPR-BASED GENOME MODIFICATION AND REGULATION
#4978METHODS FOR ALTERING GENE EXPRESSION FOR GENETIC DISORDERS
#4979Viral delivery of RNA utilizing self-cleaving ribozymes and CRISPR-based applications thereof
#4980DNA sequence modification-based gene drive
#4981GENOME EDITING METHODS FOR PRODUCING LOW-NICOTINE TOBACCO PRODUCTS
#4982Compositions and methods for the treatment of myotonic dystrophy
#4983Gene correction of Pompe disease and other autosomal recessive disorders via RNA-guided nucleases
#4984Cell model for in vitro evaluation of compound-induced skin sensitization and a constructing method therefor
#4985Enhancement of CRISPR gene editing or target destruction by co-expression of heterologous DNA repair protein
#4986CRISPR nanocomplex for nonviral genome editing and method for preparing the same
#4987BIPARTITE BASE EDITOR (BBE) ARCHITECTURES AND TYPE-II-C-CAS9 ZINC FINGER EDITING
#4988Enzyme products
#4989Engineered CRISPR-Cas9 Nucleases
#4990Genetically engineered hematopoietic stem cells and uses thereof
#4991CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous recombination of AAV donor vectors
#4992Method for identifying DNA base editing by means of cytosine deaminase
#4993CRISPR-Cas system for an algal host cell
#4994METHOD AND COMPOSITION FOR PRODUCING TARGET NUCLEIC ACID MOLECULE
#4995APOBEC ENZYMES WITH INCREASED DNA EDITING ACTIVITY, AND METHODS FOR THEIR USE
#4996Regulation of gene expression using engineered nucleases
#4997Engineered meganucleases specific for recognition sequences in the PCSK9 gene
#4998Cas13b orthologues CRISPR enzymes and systems
#4999COMPOSITION CONTAINING C2CL ENDONUCLEASE FOR DIELECTRIC CALIBRATION AND METHOD FOR DIELECTRIC CALIBRATION USING SAME
#5000METHODS AND COMPOSITIONS FOR OCULAR CELL THERAPY
#5001Recombinant vector comprising ERT2 fused to CAS9
#5002Molecular system for cancer biology
#5003MATERIALS AND METHODS FOR TREATMENT OF APOLIPOPROTEIN C3 (APOCIII)-RELATED DISORDERS
#5004RNA-targeting fusion protein compositions and methods for use
#5005A UNIVERSAL PLATFORM TO ENHANCE CRISPR-BASED GENE EDITING FOR IN VIVO THERAPIES
#5006GENE THERAPY TARGETING THE NEONATAL FORM OF NAV1.5 FOR TREATING CANCER
#5007RNA COMPOSITIONS FOR GENOME EDITING
#5008HTP genomic engineering platform for improving fungal strains
#5009HIGH-THROUGHPUT STRATEGY FOR DISSECTING MAMMALIAN GENETIC INTERACTIONS
#5010Engineered enzymes
#5011Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
#5012TGFBetaR2 endonuclease variants, compositions, and methods of use
#5013GENETICALLY MODIFIED NK-92 CELLS WITH DECREASED CD96/TIGIT EXPRESSION
#5014Polypeptides
#5015Sequence-specific antimicrobials by blocking DNA repair
#5016ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSIDS AND METHODS OF USE THEREOF
#5017Single-vector type I vectors
#5018Method of Recording Multiplexed Biological Information into a CRISPR Array Using a Retron
#5019Manufacturing and engineering of DNASE enzymes for therapy
#5020Recombinant nucleoside-specific ribonuclease and method of producing and using same
#5021COMPOSITIONS AND METHODS FOR ENHANCING GENOME EDITING
#5022Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems
#5023METHODS FOR INTEGRATION OF TRANSGENE DNA
#5024METHODS OF SELECTING CELLS COMPRISING GENOME EDITING EVENTS
#5025ENGINEERED GENETIC MODULATORS
#5026Methods and compositions for modulating a genome
#5027CBLB endonuclease variants, compositions, and methods of use
#5028FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS
#5029RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY
#5030Protein mutants that enhance the DNA cleavage activity of sp. CPF1
#5031Polypeptides having DNase activity
#5032METHODS FOR GENOME-EDITING AND ACTIVATION OF CELLS
#5033NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF
#5034METHODS FOR RARE EVENT DETECTION
#5035Method for producing DNA-edited eukaryotic cell, and kit used in the same
#5036COMPOSITIONS AND METHODS FOR INCREASING SHELF-LIFE OF BANANA
#5037EXOSOME LOADED THERAPEUTICS FOR TREATING SICKLE CELL DISEASE
#5038Compositions and methods for the treatment of hemoglobinopathies
#5039Recombinant type I CRISPR-Cas system
#5040TAL effector-mediated DNA modification
#5041Genome Editing System For Repeat Expansion Mutation
#5042COMPOSITIONS AND METHODS FOR NUCLEIC ACID AND/OR PROTEIN PAYLOAD DELIVERY
#5043Genomic engineering of pluripotent cells
#5044ENGINEERED DCAS9 WITH REDUCED TOXICITY AND ITS USE IN GENETIC CIRCUITS
#5045COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES
#5046BCL11A guide delivery
#5047MATERIALS AND METHODS FOR TREATMENT OF MEROSIN-DEFICIENT COGENITAL MUSCULAR DYSTROPHY (MDCMD) AND OTHER LAMININ, ALPHA 2 (LAMA2) GENE RELATED CONDITIONS OR DISORDERS
#5048Methods and systems for modulating intracellular gene expression
#5049Genetically engineered hematopoietic stem cells and uses thereof
#5050THERAPEUTIC CELLS
#5051FAD3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
#5052CAPTURE OF NUCLEIC ACIDS USING A NUCLEIC ACID-GUIDED NUCLEASE-BASED SYSTEM
#5053Targeting BCL11A distal regulatory elements for fetal hemoglobin reinduction
#5054METHODS AND COMPOSITIONS FOR MODIFYING A SINGLE STRANDED TARGET NUCLEIC ACID
#5055CRISPR enzyme mutations reducing off-target effects
#5056CASZ COMPOSITIONS AND METHODS OF USE
#5057Variant CAS9 proteins with improved DNA cleavage selectivity
#5058Hyperactive piggybac transposases
#5059BIOMARKERS AND CAR T CELL THERAPIES WITH ENHANCED EFFICACY
#5060Immune cells expressing engineered antigen receptors
#5061Vesicular adaptor and uses thereof in nucleic acid library construction and sequencing
#5062Method for selective translation of desired proteins in the presence of a specified nucleic acid ligand
#5063Universal donor cells
#5064Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5065METHOD FOR TARGETED ALTERATION OF DUPLEX DNA
#5066CRISPR/CAS9-BASED COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGENERATIONS
#5067UNIVERSAL DONOR CELLS
#5068CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#5069Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders
#5070Automated cell processing methods, modules, instruments, and systems
#5071CRISPR-associated (Cas) protein
#5072CRISPR-CAS SYSTEMS, CRYSTAL STRUCTURE AND USES THEREOF
#5073CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Adoptive Cell Therapy
#5074Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
#5075Compositions and methods for selective elimination and replacement of hematopoietic stem cells
#5076Thermolabile exonucleases
#5077Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing
#5078CHIMERIC PROTEINS AND METHODS OF REGULATING GENE EXPRESSION
#5079METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#5080RNA-TARGETING FUSION PROTEIN COMPOSITIONS AND METHODS FOR USE
#5081HTP genomic engineering platform for improving fungal strains
#5082RNA affinity purification
#5083Engineered nucleic-acid targeting nucleic acids
#5084Detection of nuclease edited sequences in automated modules and instruments
#5085Targeted DNA demethylation and methylation
#5086Targeted disruption of the MHC cell receptor
#5087Automated instrumentation for production of T-cell receptor peptide libraries
#5088Mutants of the bacteriophage lambda integrase
#5089Genome editing
#5090METHOD FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSIS TYPE II
#5091TRANSPOSON SYSTEM AND METHODS OF USE
#5092CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#5093DNA WRITERS, MOLECULAR RECORDERS AND USES THEREOF
#5094CRISPR DNA targeting enzymes and systems
#5095Automated cell processing methods, modules, instruments, and systems
#5096High Fidelity Restriction Endonucleases
#5097Automated instrumentation for production of peptide libraries
#5098Engineered target specific base editors
#5099METHODS AND COMPOSITIONS FOR TREATING CANCER
#5100METHODS FOR DELIVERING GENE EDITING REAGENTS TO CELLS WITHIN ORGANS